Drugs / Trivalent inactivated influenza virus vaccine
Trivalent inactivated influenza virus vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00436046 | Mar → Apr 2007 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trivalent inactivated influenza virus vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00436046 ↗ |
| Modality | Vaccine | “inactivated influenza virus vaccine (IVV)” NCT00436046 ↗ |
| Route | Intranasal | “administered once by nasal instillation” NCT00436046 ↗ |